Technical Analysis for ISR - IsoRay, Inc.

Grade Last Price % Change Price Change
grade D 0.3706 19.74% 0.06
ISR closed up 19.74 percent on Wednesday, September 18, 2019, on 9.0 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Earnings due: Sep 24

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ISR trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for ISR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.
Medicine Health Cancer Treatment Of Cancer Oncology Radiation Prostate Cancer Breast Cancer Medical Physics Radiation Therapy Colorectal Cancer Pancreatic Cancer Brain Cancer Treatment Of Prostate Cancer Esophageal Cancer Balloon Catheter Brachytherapy Liver Cancer Ocular Melanoma Pancreatic Cancers
Is ISR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.61
52 Week Low 0.269
Average Volume 136,681
200-Day Moving Average 0.39
50-Day Moving Average 0.3555
20-Day Moving Average 0.3294
10-Day Moving Average 0.3211
Average True Range 0.0251
ADX 20.74
+DI 27.6136
-DI 10.3125
Chandelier Exit (Long, 3 ATRs ) 0.3147
Chandelier Exit (Short, 3 ATRs ) 0.3826
Upper Bollinger Band 0.3689
Lower Bollinger Band 0.2899
Percent B (%b) 1.02
BandWidth 23.982999
MACD Line -0.0076
MACD Signal Line -0.0119
MACD Histogram 0.0043
Fundamentals Value
Market Cap 20.39 Million
Num Shares 55 Million
EPS -0.11
Price-to-Earnings (P/E) Ratio -3.31
Price-to-Sales 5.78
Price-to-Book 2.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.47
Resistance 3 (R3) 0.46 0.42 0.45
Resistance 2 (R2) 0.42 0.40 0.43 0.45
Resistance 1 (R1) 0.40 0.38 0.41 0.40 0.44
Pivot Point 0.35 0.35 0.36 0.36 0.35
Support 1 (S1) 0.33 0.33 0.34 0.34 0.30
Support 2 (S2) 0.29 0.31 0.29 0.29
Support 3 (S3) 0.26 0.29 0.29
Support 4 (S4) 0.27